Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma

Tohoku J Exp Med. 2024 Jan 12. doi: 10.1620/tjem.2023.J109. Online ahead of print.NO ABSTRACTPMID:38220168 | DOI:10.1620/tjem.2023.J109

Source: The Tohoku Journal of Experimental Medicine - January 14, 2024 Category: Research Authors: Yasuhiro Suzuki Yasufumi Sato Source Type: research